Mabion S.A. (WSE:MAB)
Poland · Delayed Price · Currency is PLN 7.48
-0.05 (-0.66%)
Nov 21, 2025, 5:00 PM CET
Mabion Market Cap
Mabion has a market cap or net worth of 120.89 million as of November 21, 2025. Its market cap has decreased by -34.39% in one year.
Market Cap
120.89M
Enterprise Value
113.46M
Revenue
11.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.48
Market Cap Chart
Since August 10, 2010, Mabion's market cap has increased from 93.01M to 120.89M, an increase of 29.98%. That is a compound annual growth rate of 1.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 120.89M | -15.96% |
| Dec 30, 2024 | 143.84M | -50.96% |
| Dec 29, 2023 | 293.35M | -13.57% |
| Dec 30, 2022 | 339.41M | -65.63% |
| Dec 30, 2021 | 987.46M | 246.59% |
| Dec 30, 2020 | 284.90M | -73.03% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.95B |
| NEUCA | 3.65B |
| Synektik Spólka Akcyjna | 2.22B |
| Voxel | 1.55B |
| Celon Pharma | 1.12B |
| Selvita | 826.00M |
| Centrum Medyczne ENEL-MED | 520.36M |
| Bioceltix | 453.05M |